XML 89 R67.htm IDEA: XBRL DOCUMENT v3.25.2
SHARE CAPITAL (Narrative) (Details 1)
 1 Months Ended 12 Months Ended
Feb. 29, 2024
$ / shares
Mar. 31, 2025
CAD ($)
Share
$ / shares
Mar. 31, 2024
CAD ($)
Share
$ / shares
Consultants, employees and directors [Member]      
Disclosure of classes of share capital [line items]      
Number of stock options granted | Share   2,000,000 1,250,000
Grant date fair value of stock options granted | $   $ 1,802,247 $ 1,545,175
Description of vesting   621,250 at the date of issuance; 661,250 after 12 months from the date of issuance; 621,250 after 24 months from the date of issuance; and 96,250 after 36 months from the date of issuance. 416,667 at the date of issuance; 350,000 after 6 months from the date of issuance; 416,667 after 12 months from the date of issuance; and 66,667 after 24 months from the date of issuance.
Consultants, employees and directors [Member] | Minimum [Member]      
Disclosure of classes of share capital [line items]      
Exercise price | $ / shares   $ 1.42 $ 1.75
Consultants, employees and directors [Member] | Maximum [Member]      
Disclosure of classes of share capital [line items]      
Exercise price | $ / shares   $ 1.52 $ 2.24
Triera Biosciences Ltd [Member]      
Disclosure of classes of share capital [line items]      
Number of stock options granted | Share   5,000 195,000
Triera Biosciences Ltd [Member] | Consultants [Member]      
Disclosure of classes of share capital [line items]      
Number of stock options granted | Share   5,000  
Exercise price | $ / shares   $ 1  
Description of vesting   The vesting period for the Triera stock options issued was as follows: 1,667 on June 1, 2024; 1,667 on June 1, 2025; and 1,666 on June 1, 2026.  
Triera Biosciences Ltd [Member] | Directors and Officers [Member]      
Disclosure of classes of share capital [line items]      
Number of stock options granted | Share     195,000
Exercise price | $ / shares $ 1   $ 5
Description of vesting     The vesting period for the Triera stock options issued was as follows: 65,000 at the date of issuance; 65,000 after 6 months from the date of issuance; and 65,000 after 12 months from the date of issuance. In February 2024, the Company repriced the Triera stock options, reducing the exercise price from $5.00 per share to $1.00 per share.